[EN] COMPOUNDS FOR THE TREATMENT OF HEPATITIS C<br/>[FR] COMPOSÉS POUR LE TRAITEMENT DE L'HÉPATITE C
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2012024373A1
公开(公告)日:2012-02-23
The disclosure provides compounds of formula (I), including pharmaceutically acceptable salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV. (Formula (I))
该披露提供了公式(I)的化合物,包括药用可接受的盐,以及使用这些化合物的组合物和方法。这些化合物对丙型肝炎病毒(HCV)具有活性,并可能对感染HCV的人有用。(公式(I))